The report on Cancer Immunotherapy Market by therapeutic area (lung, melanoma, breast, colorectal, blood,
prostate cancer), end users (hospitals, ambulatory surgical centers, clinics), therapy type (monoclonal
antibodies, system modulators, immune checkpoint inhibitors, vaccines) trends analysis and forecasts up to
2024 studies the market sizes, key trends and opportunities in the main geographies such as North America,
Europe, Asia-Pacific, Rest of the World. According to the report the Global Cancer Immunotherapy Market is
projected to grow at a CAGR of 14.5% in terms of value over the period of 2018-2024. The growth in the
world market is primarily driven by significant contribution by North America (Leading region) region to this
market.
Get a Sample Request
https://www.infiniumglobalresearch.com/reports/sample_request/1095
Segments Covered
The report on global cancer immunotherapy market covers segments such as therapeutic area, end users, and
therapy type. The therapeutic area segments include lung cancer, melanoma, breast cancer, colorectal cancer,
blood cancer, prostate cancer and others. On the basis of end users the global cancer immunotherapy market
is categorized into hospitals, ASC’S (ambulatory surgical centers), clinics and cancer research centers.
Furthermore, on the basis of therapy type the cancer immunotherapy market is segmented as monoclonal
antibodies, immune system modulators, immune checkpoint inhibitors, cancer vaccines and others.
Geographic Coverage
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and
Rest of the World. In this section the key trends and market size for each geography is provided over the
period of 2016 – 2024.
Infinium Global Research